My Treatment Approach: Optimizing Care for Relapsed / Refractory Multiple Myeloma: Translating Evidence to Clinical Practice - Episode 3
Real Life Clinical Practice Use of Selinexor: Dosing Strategies, Supportive Care, and Strategies to Incorporate into Novel Selinexor-Based Regimens
The key opinion leaders examine selinexor combinations and dosing strategies they currently employ, while also addressing how the frequency of treatment-related adverse events (TRAEs) associated with selinexor varies with lower dosing regimens in the context of managing early relapse multiple myeloma.
Video Player is loading.
Video content above is prompted by the following:
- What selinexor combinations & doses are you currently using in your clinical practice?
- What has your experience been with selinexor based-regimens? How have the frequency of TRAEs associated with Selinexor differed with lower dosing?
- What has your experience been with selinexor based-regimens? How have the frequency of TRAEs associated with Selinexor differed with lower dosing?
- Please comment on any differences or similarities between your Selinexor prescribing patterns & experiences.
Related Content:
